Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Κύριος συγγραφέας: | Tear, L |
---|---|
Άλλοι συγγραφείς: | Faulkner, S |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2018
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
ανά: T Mortezazadeh, κ.ά.
Έκδοση: (2020-02-01) -
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
ανά: Zahra Sahraei, κ.ά.
Έκδοση: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
ανά: Marco Moscatelli, κ.ά.
Έκδοση: (2023-10-01) -
Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
ανά: Caterina Beatrice Monti, κ.ά.
Έκδοση: (2020-04-01) -
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
ανά: Simona Bussi, κ.ά.
Έκδοση: (2020-02-01)